VA Medical Center (90C), University & Woodland Aves, Philadelphia, PA 19104

66 -- LABORATORY EQUIPMENT SOL 642-10-97 DUE 041497 POC Janet L. Mason 215-823-5120 BIOCHEM IMMUNOSYSTEMS LABOTECH AUTOMATED MICROPLATE ANALYZER The Department of Veterans Affairs, Philadelphia VA Medical Center, intends to award a Sole-Source contract to BioChem ImmunoSystems, Inc. for the Labotech Automated Microplate Analyzer. Basic features of the automated microplate analyzer must include the following: Fully automated open system instrument for processing of EIA microtiter assays; allows for use of many different tests by multiple manufacturers with the ability to add new assays as they develop; primary tube sampling and sample dilution which reduces the danger of biohazards; instrument must be bi-directionally interfaced which allows for the use of barcoded samples, minimizing potential for incorrect patient testing; features an integrated quality control program utilizing Levey-Jennings charts; test include but are not limited to: Meridian Premier Cryptosporidium, Elias dsDNA Abs, Elias ANA Rheuma Screen, Meridian Premier C. difficile, Zeus Lyme IgG/IgM, Elias M2 Abs, MeridianPremier Giardia, Centocor Captis Syphillis-G, Zeus Measles IgG, Elias TGAb, Elias TPO (microsomal) Abs, UBI HIV 1/2, Elias H. pyloric Abs, Elias Cardiolipin Abs Screen and Zeus Toxoplasma IgG. All responsible sources may submit written responses which include pricing, GSA contract number (if applicable), descriptive literature of alternative automated microplate analyzers in sufficient detail to permit technical evaluation, and point of contact (Name and Telephone No.). The automated microplate analyzer must include as a minimum, all basic features listed and available for direct purchase and/or cost-per-test agreement. This is not an invitation to bid, request for proposal or quotation and is not to be construed as a commitment to issue an IFB, RFP, or RFQ. No solicitation document exists. Information received shall be considered solely for the purpose of determining whether or not to conduct a competitive procurement. A determination by the Government not to compete this requirement based on responses to this notice is solely within the discretion of the Government. All responses received will be fully considered by Philadelphia VA Medical Center. If no affirmative response is received from another source, a contract will be awarded to BioChem ImmunoSystems, Inc. See Numbered Note 22. (0072)

Loren Data Corp. http://www.ld.com (SYN# 0273 19970318\66-0012.SOL)